Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayral

Showing results (211-220 of 220) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 220 results.
Journal of Human Genetics|May 22, 2023
Genome sequencing identifies coding and non-coding variants for non-syndromic hearing lossMemoona Ramzan, Duygu Duman, LeShon Chere Peart Hendricks, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamatesJ I Levin, J M Chen, K Cheung, et al.
Molecular Psychiatry|February 11, 2009
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's diseaseJ Chapuis, D Hot, F Hansmannel, et al.
JAMA Network Open|November 16, 2022
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality TherapyAnthony M Magliocco, Jennifer Moughan, David T Miyamoto, et al.
Nature Communications|October 10, 2025
Estrogen-related receptor gene expression associates with sex differences in cortical atrophy in isolated REM sleep behavior disorderMarie Filiatrault, Violette Ayral, Christina Tremblay, et al.
Elife|March 15, 2018
IRF4 haploinsufficiency in a family with Whipple's diseaseAntoine Guérin, Gaspard Kerner, Nico Marr, et al.
Ebiomedicine|June 23, 2016
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's DiseaseFlorent Letronne, Geoffroy Laumet, Anne-Marie Ayral, et al.
Acta Neuropathologica|December 10, 2016
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolismJulien Chapuis, Amandine Flaig, Benjamin Grenier-Boley, et al.
Molecular Psychiatry|February 13, 2013
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathologyJ Chapuis, F Hansmannel, M Gistelinck, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Non-microglial downregulation of <i>PLCG2</i> impairs synaptic function and elicits Alzheimer disease-related hallmarksAudrey Coulon, Florian Rabiller, Mari Takalo, et al.
Pageof 22

Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
Journal of Human Genetics|May 22, 2023
Genome sequencing identifies coding and non-coding variants for non-syndromic hearing lossMemoona Ramzan, Duygu Duman, LeShon Chere Peart Hendricks, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamatesJ I Levin, J M Chen, K Cheung, et al.
Molecular Psychiatry|February 11, 2009
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's diseaseJ Chapuis, D Hot, F Hansmannel, et al.
JAMA Network Open|November 16, 2022
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality TherapyAnthony M Magliocco, Jennifer Moughan, David T Miyamoto, et al.
Nature Communications|October 10, 2025
Estrogen-related receptor gene expression associates with sex differences in cortical atrophy in isolated REM sleep behavior disorderMarie Filiatrault, Violette Ayral, Christina Tremblay, et al.
Elife|March 15, 2018
IRF4 haploinsufficiency in a family with Whipple's diseaseAntoine Guérin, Gaspard Kerner, Nico Marr, et al.
Ebiomedicine|June 23, 2016
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's DiseaseFlorent Letronne, Geoffroy Laumet, Anne-Marie Ayral, et al.
Acta Neuropathologica|December 10, 2016
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolismJulien Chapuis, Amandine Flaig, Benjamin Grenier-Boley, et al.
Molecular Psychiatry|February 13, 2013
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathologyJ Chapuis, F Hansmannel, M Gistelinck, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Non-microglial downregulation of <i>PLCG2</i> impairs synaptic function and elicits Alzheimer disease-related hallmarksAudrey Coulon, Florian Rabiller, Mari Takalo, et al.
Pageof 22